跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIXUBIS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RIXUBIS
Authorized
STANDARD
RIXUBIS
takeda canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ccfeed6386387d6f
Company
takeda canada inc
Type
Standard
Approval Details
Approval Id
ccfeed6386387d6f
Drug Approval Canada Name
RIXUBIS
Product Name
RIXUBIS
Status
Dormant
Status Date
2024-11-06
Original Market Date
2019-01-15
Din
02431920
Drug Class
Human
Dosage Form
Kit , Powder For Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BD04 COAGULATION FACTOR IX
Atc Name
b 02 bd 04
Aig Number
0156050001
Company Name
takeda canada inc
Company Address
3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3
Active Ingredients
NONACOG GAMMA
250 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ccfeed6386387d6f
Type
Standard
Back to Health Canada Approvals